Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01853696 · ClinicalTrials.gov registry record · Phase 4
Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty
A Phase 4 study, sponsored by Cornea Research Foundation of America.
- Completed
- Registry status
- Phase 4
- Development phase
- 167
- Enrollment target
NCT01853696 is a Phase 4 study that has completed, run by Cornea Research Foundation of America. The registered enrollment target is 167 participants.
The verdict
NCT01853696, a Phase 4 study, has completed, sponsored by Cornea Research Foundation of America.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 167 participants
- Enrollment target
Study Summary
Graft rejection has traditionally been one of the leading causes of cornea transplant failure. To help prevent rejection, corticosteroid eye drops are used for an extended period after transplant surgery. The purpose of this study is to compare the efficacy and side effects of different corticosteroid dosing regimens after endothelial keratoplasty (cornea transplant) surgery.
Interventions
- DRUG loteprednol etabonate
- DRUG prednisolone acetate 1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01853696
The ClinicalTrials.gov registry entry for NCT01853696 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cornea Research Foundation of America, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which loteprednol etabonate is the first listed.
NCT01853696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01853696 about?
NCT01853696 is a clinical study titled "Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty". Graft rejection has traditionally been one of the leading causes of cornea transplant failure. To help prevent rejection, corticosteroid eye drops are used for an extended period after transplant surgery. The purpose of this study is to compare the efficacy and side effects of different corticostero...
What is the current status of trial NCT01853696?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 167 participants. The study started on 2013-03. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01853696?
The interventions under investigation include: loteprednol etabonate (DRUG), prednisolone acetate 1% (DRUG).
Who is sponsoring clinical trial NCT01853696?
This trial is sponsored by Cornea Research Foundation of America, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.